Paris, France

Nuria Merayo Merayo

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 20.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Paris, FR (2018 - 2021)
  • Romainville, FR (2019 - 2021)

Company Filing History:


Years Active: 2018-2021

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: **Nuria Merayo Merayo: Innovator in Cystic Fibrosis Treatments**

Introduction

Nuria Merayo Merayo is a distinguished inventor based in Paris, France, recognized for her significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 10 patents, her work primarily focuses on the development of treatments for cystic fibrosis, a life-threatening genetic disorder.

Latest Patents

Among her latest inventions, Merayo has developed modulators of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This invention showcases compounds of Formula (I), detailing specific molecular structures defined by the parameters A, R, R, R, R, and n. The innovative compounds are intended for the treatment of cystic fibrosis, highlighting methods for their production and pharmaceutical compositions. Furthermore, these compounds are pivotal in administering effective treatments for patients suffering from this condition.

Career Highlights

Throughout her career, Nuria Merayo has collaborated with prominent companies in the pharmaceutical sector, notably Galapagos NV and AbbVie Overseas S.à r.l. Her experience in these organizations has enabled her to advance her research and contribute significantly to medical science.

Collaborations

Merayo has worked alongside notable coworkers, including Nicolas Desroy and Gregory A. Gfesser. These collaborations have enriched her work environment and fostered an atmosphere of innovation, allowing for the exchange of ideas and enhancement of research outcomes.

Conclusion

Nuria Merayo Merayo stands out as a leading inventor whose contributions to cystic fibrosis treatments have the potential to transform lives. Her patents reflect a commitment to advancing medical science, showing her dedication to improving patient care and health outcomes. Her ongoing work continues to inspire future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…